Arrayit

The deal brings together three firms that have struggled to ramp their test businesses in hopes that the combined outfit will be better positioned to succeed.

Arrayit also alleged that the actions of an investor suing the company threatens a company contract with the US Department of Agriculture.

In a letter to a New York court, the investor alleged that Arrayit has failed to meet the terms of a settlement that was supposed to end litigation filed last year.

The partners will collaborate to develop and validate a high-throughput DNA microarray-based detection system to monitor foodborne bacteria and viruses. 

NEW YORK (GenomeWeb) – Avant Diagnostics plans to go public through a reverse merger effective Oct.

NEW YORK (GenomeWeb) – American Liberty Petroleum Corp. has announced plans to acquire Avant Diagnostics, a Scottsdale, Ariz.-based company seeking to commercialize OvaDx, a microarray-based test for early stage ovarian cancer detection.

NEW YORK (GenomeWeb) – Arrayit disclosed in a regulatory filing this week that a lawsuit filed by an investor against several members of its management team has recently been dismissed.

NEW YORK (GenomeWeb) – Arrayit today said that it has signed a distribution agreement with VigeneTech, bundling that firm's protein microarray suite of software with Arrayit's protein microarray platform.

NEW YORK (GenomeWeb) – Arrayit today reported a 15 percent spike in first quarter sales driven by sales of microarray instruments.
Total revenues for the three months ended March 31 were $1.1 million up from $942,916 in the first quarter of 2013.

NEW YORK (GenomeWeb News) – Arrayit said today it has inked a professional services master agreement with Diagnostic Oncology Research Organization to aid it in obtaining approval from the US Food and Drug Administration for its tests.

Pages

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.